Results 1 to 10 of about 7,125 (154)
Neuromyelitis optica spectrum disorders [PDF]
Therapeutic Advances in Neurological DisordersMohammad Ali Sahraian, Kazuo Fujihara
doaj +3 more sources
Treatment of Neuromyelitis Optica Spectrum Disorders [PDF]
International Journal of Molecular Sciences, 2021 Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system (CNS) inflammatory disorder that can lead to serious disability and mortality. Females are predominantly affected, including those within the reproductive age. Most patients develop relapsing attacks of optic neuritis; longitudinally extensive transverse myelitis ...
Koon-Ho Chan, Chan Koon-Ho
exaly +3 more sources
Neuromyelitis optica spectrum disorders: An update
Annals of Indian Academy of Neurology, 2015 Recent advances in the understanding of neuromyelitis optica spectrum of disorders (NMOSD) have expanded. Diagnostic criteria have changed over the years.
Lekha Pandit
doaj +3 more sources
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neurology and Therapy, 2019 Introduction Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disease of the central nervous system. NMOSD starting after the age of 50 years is considered a “late onset” (LO-NMOSD) and seems to be particularly aggressive ...
Yara Dadalti Fragoso +15 more
doaj +3 more sources
Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders
Frontiers in Cellular Neuroscience, 2019 Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder mediated by immune-humoral responses directed against central nervous system (CNS) antigens.
Ana Paula Bornes da Silva +6 more
doaj +3 more sources
Neuromyelitis optica spectrum disorders [PDF]
Journal of the Neurological Sciences, 2021 The disease concept of Neuromyelitis Optica Spectrum Disorders(NMOSD) has undergone a significant change over the last two decades including the detection of Myelin Oligodendrocyte Glycoprotein(MOG) antibody in patients who are seronegative for aquaporin-4 antibody.
Shabeer, Paul +4 more
openaire +2 more sources
Neuromyelitis optica spectrum disorders [PDF]
Clinical Medicine, 2019 Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon antibody-mediated disease of the central nervous system. Long segments of spinal cord inflammation (myelitis), severe optic neuritis, and/or bouts of intractable vomiting and hiccoughs (area postrema syndrome) are classic presentations of the disease and may alert the clinician to the ...
Saif Huda +6 more
+5 more sources
Frontiers in Neurology, 2022 BackgroundNeuromyelitis optica spectrum disorders seriously hinder social participation. Only clarifying the status of social participation and the factors most strongly influencing it can promote better-targeted support for those with neuromyelitis ...
Mengmeng Jia +7 more
doaj +1 more source
Neuromyelitis optica spectrum disorders and pregnancy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2022 Neuromyelitis optica spectrum diseases (NMOSDs) is an autoimmune disease of central nervous system, which occurs frequently in women of childbearing age. NMOSDs may affect pregnancy planning and fertility, and the effect on pregnancy outcome is not clear.
LIU Qiang, ZHANG Qing, QUAN Chao
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Neuromyelitis optica spectrum disorders can less commonly present with area postrema syndrome progressing to myelitis. Management involves intravenous glucocorticoids, plasma exchange, and preventive immunotherapy.
Preethi Jagannath +6 more
doaj +1 more source